Unmet Needs in Clinical Research Hepatitis B
Author:
Dusheiko Geoffrey
Publisher
Springer Singapore
Reference64 articles.
1. Aberra H, Desalegn H, Berhe N, Mekasha B, Medhin G, Gundersen SG, et al. The WHO guidelines for chronic hepatitis B fail to detect half of the patients in need of treatment in Ethiopia. J Hepatol. 2019;70(6):1065–71. https://doi.org/10.1016/j.jhep.2019.01.037.
2. Atsama MA, Marchio A, Bivigou-Mboumba B, Noah Noah D, Banai R, Atangana PJA, et al. Enrichment in selected genotypes, basal core and precore mutations of hepatitis B virus in patients with hepatocellular carcinoma in Cameroon. J Viral Hepat. 2019; https://doi.org/10.1111/jvh.13131.
3. Bath RM, Doering BE, Nailor MD, Goodlet KJ. Pharmacotherapy-induced hepatitis B reactivation among patients with prior functional cure: a systematic review. Ann Pharmacother. 2019;53(3):294–310. https://doi.org/10.1177/1060028018800501.
4. Berg T, Simon KG, Mauss S, Schott E, Heyne R, Klass DM, et al. Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study. J Hepatol. 2017;67(5):918–24. https://doi.org/10.1016/j.jhep.2017.07.012.
5. Berke JM, Dehertogh P, Vergauwen K, Mostmans W, Vandyck K, Raboisson P, et al. Antiviral properties and mechanism of action studies of the hepatitis B virus capsid assembly modulator JNJ-56136379. Antimicrob Agents Chemother. 2020; https://doi.org/10.1128/aac.02439-19.